Qiu Meng, Yuwen Zhou, Ping Chen, Jin Wang, Yongdong Jin, Yan Li, Chuan Chen, Hong Qiu, Yanmin Shen, Qing Qiao, Hao Liu, Li Huang, Lin Xie, Yanhong Deng, Lei Yang, Li Zhang, Xiaofen Li, Jianjun Li, Shisheng Tan, Tao Zhang. "A multicenter randomized phase II trial assessing the efficacy and safety of mCapOX plus cetuximab with mFOLFOX6 plus cetuximab as first-line treatment for
                    <i>RAS/BRAF</i>
                    wild-type metastatic colorectal cancer: Updated results from the CAPCET study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3598